APO Research
Talk to an analyst

APO RESEARCH · REPORT

Poloxamer

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Poloxamer Industry Growth and Trends Forecast to 2032

27 December 202591 pages

Choose your research edition.

Industry ResearchPoloxamer Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Poloxamer Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Poloxamer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Poloxamer Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Poloxamer Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Poloxamer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Poloxamer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Poloxamer is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Poloxamer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Poloxamer include BASF, ADEKA, Croda, Nanjing Well, Hubei Hengshuo, Solvay and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Poloxamer market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Poloxamer market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Poloxamer market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Poloxamer.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Poloxamer market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Poloxamer Market by Company

BASF

ADEKA

Croda

Nanjing Well

Hubei Hengshuo

Solvay

Merck KGaA

Poloxamer Segment by Type

Poloxamer 124

Poloxamer 184

Poloxamer 188

Poloxamer 338

Poloxamer 407

Others

Poloxamer Segment by Application

Cosmetics Industrial

Biologics

Pharmaceutical Industrial

Others

Poloxamer Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poloxamer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Poloxamer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Poloxamer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Poloxamer 124 Table 2. Major Company of Poloxamer 184 Table 3. Major Company of Poloxamer 188 Table 4. Major Company of Poloxamer 338 Table 5. Major Company of Poloxamer 407 Table 6. Major Company of Others Table 7. Global Poloxamer Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Poloxamer Sales by Type (2021-2026) & (Tons) Table 9. Global Poloxamer Sales Market Share in Volume by Type (2021-2026) Table 10. Global Poloxamer Sales by Type (2021-2026) & (US$ Million) Table 11. Global Poloxamer Sales Market Share in Value by Type (2021-2026) Table 12. Global Poloxamer Price by Type (2021-2026) & (US$/Ton) Table 13. Global Poloxamer Sales by Type (2027-2032) & (Tons) Table 14. Global Poloxamer Sales Market Share in Volume by Type (2027-2032) Table 15. Global Poloxamer Sales by Type (2027-2032) & (US$ Million) Table 16. Global Poloxamer Sales Market Share in Value by Type (2027-2032) Table 17. Global Poloxamer Price by Type (2027-2032) & (US$/Ton) Table 18. North America Poloxamer Sales by Type (2021-2026) & (Tons) Table 19. North America Poloxamer Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Poloxamer Sales by Type (2021-2026) & (Tons) Table 21. Europe Poloxamer Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Poloxamer Sales by Type (2021-2026) & (Tons) Table 23. Asia-Pacific Poloxamer Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Poloxamer Sales by Type (2021-2026) & (Tons) Table 25. Latin America Poloxamer Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Poloxamer Sales by Type (2021-2026) & (Tons) Table 27. Middle East and Africa Poloxamer Sales by Type (2021-2026) & (US$ Million) Table 28. Poloxamer Industry Trends Table 29. Poloxamer Industry Drivers Table 30. Poloxamer Industry Opportunities and Challenges Table 31. Poloxamer Industry Restraints Table 32. Global Poloxamer Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Poloxamer Revenue Market Share by Company (2021-2026) Table 34. Global Poloxamer Sales by Company (2021-2026) & (Tons) Table 35. Global Poloxamer Sales Share by Company (2021-2026) Table 36. Global Poloxamer Market Price by Company (2021-2026) & (US$/Ton) Table 37. Global Poloxamer Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Poloxamer Major Company Production Sites and Headquarters Table 39. Global Poloxamer Company, Product Type & Application Table 40. Global Poloxamer Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Poloxamer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Poloxamer Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Poloxamer Sales by Region (2021-2026) & (Tons) Table 45. Global Poloxamer Sales Market Share in Volume by Region (2021-2026) Table 46. Global Poloxamer Sales by Region (2021-2026) & (US$ Million) Table 47. Global Poloxamer Sales Market Share in Value by Region (2021-2026) Table 48. Global Poloxamer Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 49. Global Poloxamer Sales by Region (2027-2032) & (Tons) Table 50. Global Poloxamer Sales Market Share in Volume by Region (2027-2032) Table 51. Global Poloxamer Sales by Region (2027-2032) & (US$ Million) Table 52. Global Poloxamer Sales Market Share in Value by Region (2027-2032) Table 53. Global Poloxamer Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 54. Global Poloxamer Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Poloxamer Sales by Application (2021-2026) & (Tons) Table 56. Global Poloxamer Sales Market Share in Volume by Application (2021-2026) Table 57. Global Poloxamer Sales by Application (2021-2026) & (US$ Million) Table 58. Global Poloxamer Sales Market Share in Value by Application (2021-2026) Table 59. Global Poloxamer Price by Application (2021-2026) & (US$/Ton) Table 60. Global Poloxamer Sales by Application (2027-2032) & (Tons) Table 61. Global Poloxamer Sales Market Share in Volume by Application (2027-2032) Table 62. Global Poloxamer Sales by Application (2027-2032) & (US$ Million) Table 63. Global Poloxamer Sales Market Share in Value by Application (2027-2032) Table 64. Global Poloxamer Price by Application (2027-2032) & (US$/Ton) Table 65. North America Poloxamer Sales by Application (2021-2026) & (Tons) Table 66. North America Poloxamer Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Poloxamer Sales by Application (2021-2026) & (Tons) Table 68. Europe Poloxamer Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Poloxamer Sales by Application (2021-2026) & (Tons) Table 70. Asia-Pacific Poloxamer Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Poloxamer Sales by Application (2021-2026) & (Tons) Table 72. Latin America Poloxamer Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Poloxamer Sales by Application (2021-2026) & (Tons) Table 74. Middle East and Africa Poloxamer Sales by Application (2021-2026) & (US$ Million) Table 75. BASF Company Information Table 76. BASF Business Overview Table 77. BASF Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. BASF Poloxamer Product Portfolio Table 79. BASF Recent Development Table 80. ADEKA Company Information Table 81. ADEKA Business Overview Table 82. ADEKA Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. ADEKA Poloxamer Product Portfolio Table 84. ADEKA Recent Development Table 85. Croda Company Information Table 86. Croda Business Overview Table 87. Croda Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Croda Poloxamer Product Portfolio Table 89. Croda Recent Development Table 90. Nanjing Well Company Information Table 91. Nanjing Well Business Overview Table 92. Nanjing Well Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Nanjing Well Poloxamer Product Portfolio Table 94. Nanjing Well Recent Development Table 95. Hubei Hengshuo Company Information Table 96. Hubei Hengshuo Business Overview Table 97. Hubei Hengshuo Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Hubei Hengshuo Poloxamer Product Portfolio Table 99. Hubei Hengshuo Recent Development Table 100. Solvay Company Information Table 101. Solvay Business Overview Table 102. Solvay Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Solvay Poloxamer Product Portfolio Table 104. Solvay Recent Development Table 105. Merck KGaA Company Information Table 106. Merck KGaA Business Overview Table 107. Merck KGaA Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Merck KGaA Poloxamer Product Portfolio Table 109. Merck KGaA Recent Development Table 110. North America Poloxamer Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 111. North America Poloxamer Sales by Country (2021-2026) & (Tons) Table 112. North America Poloxamer Sales Market Share by Country (2021-2026) Table 113. North America Poloxamer Sales Forecast by Country (2027-2032) & (Tons) Table 114. North America Poloxamer Sales Market Share Forecast by Country (2027-2032) Table 115. North America Poloxamer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. North America Poloxamer Market Size by Country (2021-2026) & (US$ Million) Table 117. North America Poloxamer Market Share by Country (2021-2026) Table 118. North America Poloxamer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. North America Poloxamer Market Share Forecast by Country (2027-2032) Table 120. Europe Poloxamer Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 121. Europe Poloxamer Sales by Country (2021-2026) & (Tons) Table 122. Europe Poloxamer Sales Market Share by Country (2021-2026) Table 123. Europe Poloxamer Sales Forecast by Country (2027-2032) & (Tons) Table 124. Europe Poloxamer Sales Market Share Forecast by Country (2027-2032) Table 125. Europe Poloxamer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Europe Poloxamer Market Size by Country (2021-2026) & (US$ Million) Table 127. Europe Poloxamer Market Share by Country (2021-2026) Table 128. Europe Poloxamer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Europe Poloxamer Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Poloxamer Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Poloxamer Sales by Country (2021-2026) & (Tons) Table 132. Asia-Pacific Poloxamer Sales Market Share by Country (2021-2026) Table 133. Asia-Pacific Poloxamer Sales Forecast by Country (2027-2032) & (Tons) Table 134. Asia-Pacific Poloxamer Sales Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Poloxamer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Poloxamer Market Size by Country (2021-2026) & (US$ Million) Table 137. Asia-Pacific Poloxamer Market Share by Country (2021-2026) Table 138. Asia-Pacific Poloxamer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Asia-Pacific Poloxamer Market Share Forecast by Country (2027-2032) Table 140. Latin America Poloxamer Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 141. Latin America Poloxamer Sales by Country (2021-2026) & (Tons) Table 142. Latin America Poloxamer Sales Market Share by Country (2021-2026) Table 143. Latin America Poloxamer Sales Forecast by Country (2027-2032) & (Tons) Table 144. Latin America Poloxamer Sales Market Share Forecast by Country (2027-2032) Table 145. Latin America Poloxamer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Latin America Poloxamer Market Size by Country (2021-2026) & (US$ Million) Table 147. Latin America Poloxamer Market Share by Country (2021-2026) Table 148. Latin America Poloxamer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Latin America Poloxamer Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Poloxamer Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Poloxamer Sales by Country (2021-2026) & (Tons) Table 152. Middle East and Africa Poloxamer Sales Market Share by Country (2021-2026) Table 153. Middle East and Africa Poloxamer Sales Forecast by Country (2027-2032) & (Tons) Table 154. Middle East and Africa Poloxamer Sales Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Poloxamer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Poloxamer Market Size by Country (2021-2026) & (US$ Million) Table 157. Middle East and Africa Poloxamer Market Share by Country (2021-2026) Table 158. Middle East and Africa Poloxamer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Middle East and Africa Poloxamer Market Share Forecast by Country (2027-2032) Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Poloxamer Distributors List Table 163. Poloxamer Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Poloxamer Image Figure 2. Global Poloxamer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poloxamer Market Size (2021-2032) & (US$ Million) Figure 4. Global Poloxamer Sales (2021-2032) & (Tons) Figure 5. Poloxamer 124 Image Figure 6. Global Poloxamer 124 Sales YoY Growth (2021-2032) & (Tons) Figure 7. Poloxamer 184 Image Figure 8. Global Poloxamer 184 Sales YoY Growth (2021-2032) & (Tons) Figure 9. Poloxamer 188 Image Figure 10. Global Poloxamer 188 Sales YoY Growth (2021-2032) & (Tons) Figure 11. Poloxamer 338 Image Figure 12. Global Poloxamer 338 Sales YoY Growth (2021-2032) & (Tons) Figure 13. Poloxamer 407 Image Figure 14. Global Poloxamer 407 Sales YoY Growth (2021-2032) & (Tons) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 17. Global Poloxamer Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Poloxamer Market Share by Type 2025 VS 2032 Figure 19. North America Poloxamer Sales Market Share in Volume by Type in 2025 Figure 20. North America Poloxamer Sales Market Share in Value by Type in 2025 Figure 21. Europe Poloxamer Sales Market Share in Volume by Type in 2025 Figure 22. Europe Poloxamer Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Poloxamer Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Poloxamer Sales Market Share in Value by Type in 2025 Figure 25. Latin America Poloxamer Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Poloxamer Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Poloxamer Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Poloxamer Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Poloxamer Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Cosmetics Industrial Image Figure 32. Global Cosmetics Industrial Sales YoY Growth (2021-2032) & (Tons) Figure 33. Biologics Image Figure 34. Global Biologics Sales YoY Growth (2021-2032) & (Tons) Figure 35. Pharmaceutical Industrial Image Figure 36. Global Pharmaceutical Industrial Sales YoY Growth (2021-2032) & (Tons) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 39. Global Poloxamer Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Poloxamer Market Share by Application 2025 VS 2032 Figure 41. North America Poloxamer Sales Market Share in Volume by Application in 2025 Figure 42. North America Poloxamer Sales Market Share in Value by Application in 2025 Figure 43. Europe Poloxamer Sales Market Share in Volume by Application in 2025 Figure 44. Europe Poloxamer Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Poloxamer Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Poloxamer Sales Market Share in Value by Application in 2025 Figure 47. Latin America Poloxamer Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Poloxamer Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Poloxamer Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Poloxamer Sales Market Share in Value by Application in 2025 Figure 51. North America Poloxamer Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. North America Poloxamer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Poloxamer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Poloxamer Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Poloxamer Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Europe Poloxamer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Poloxamer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Poloxamer Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Poloxamer Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Asia-Pacific Poloxamer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Poloxamer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Poloxamer Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Poloxamer Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 64. Latin America Poloxamer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Poloxamer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Poloxamer Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Poloxamer Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 68. Middle East and Africa Poloxamer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Poloxamer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Poloxamer Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Poloxamer Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Poloxamer Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Poloxamer 124
  • Poloxamer 184
  • Poloxamer 188
  • Poloxamer 338
  • Poloxamer 407
  • Others
Applications
  • Cosmetics Industrial
  • Biologics
  • Pharmaceutical Industrial
  • Others
Companies covered
  • BASF
  • ADEKA
  • Croda
  • Nanjing Well
  • Hubei Hengshuo
  • Solvay
  • Merck KGaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Poloxamer Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Poloxamer Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Poloxamer Market by Type
  6. 1.3.1 Poloxamer 124
  7. 1.3.2 Poloxamer 184
  8. 1.3.3 Poloxamer 188
  9. 1.3.4 Poloxamer 338
  10. 1.3.5 Poloxamer 407
  11. 1.3.6 Others
  12. 1.4 Global Poloxamer Market Size by Type
  13. 1.4.1 Global Poloxamer Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Poloxamer Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Poloxamer Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Poloxamer Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Poloxamer Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Poloxamer Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Poloxamer Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Poloxamer Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Poloxamer Industry Trends
  2. 2.2 Poloxamer Industry Drivers
  3. 2.3 Poloxamer Industry Opportunities and Challenges
  4. 2.4 Poloxamer Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Poloxamer Revenue (2021-2026)
  2. 3.2 Global Top Players by Poloxamer Sales (2021-2026)
  3. 3.3 Global Top Players by Poloxamer Price (2021-2026)
  4. 3.4 Global Poloxamer Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Poloxamer Major Company Production Sites & Headquarters
  6. 3.6 Global Poloxamer Company, Product Type & Application
  7. 3.7 Global Poloxamer Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Poloxamer Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Poloxamer Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Poloxamer Tier 1, Tier 2, and Tier 3
4 Poloxamer Regional Status and Outlook
  1. 4.1 Global Poloxamer Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Poloxamer Historic Market Size by Region
  3. 4.2.1 Global Poloxamer Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Poloxamer Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Poloxamer Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Poloxamer Forecasted Market Size by Region
  7. 4.3.1 Global Poloxamer Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Poloxamer Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Poloxamer Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Poloxamer by Application
  1. 5.1 Poloxamer Market by Application
  2. 5.1.1 Cosmetics Industrial
  3. 5.1.2 Biologics
  4. 5.1.3 Pharmaceutical Industrial
  5. 5.1.4 Others
  6. 5.2 Global Poloxamer Market Size by Application
  7. 5.2.1 Global Poloxamer Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Poloxamer Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Poloxamer Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Poloxamer Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Poloxamer Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Poloxamer Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Poloxamer Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Poloxamer Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BASF
  2. 6.1.1 BASF Company Information
  3. 6.1.2 BASF Business Overview
  4. 6.1.3 BASF Poloxamer Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BASF Poloxamer Product Portfolio
  6. 6.1.5 BASF Recent Developments
  7. 6.2 ADEKA
  8. 6.2.1 ADEKA Company Information
  9. 6.2.2 ADEKA Business Overview
  10. 6.2.3 ADEKA Poloxamer Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ADEKA Poloxamer Product Portfolio
  12. 6.2.5 ADEKA Recent Developments
  13. 6.3 Croda
  14. 6.3.1 Croda Company Information
  15. 6.3.2 Croda Business Overview
  16. 6.3.3 Croda Poloxamer Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Croda Poloxamer Product Portfolio
  18. 6.3.5 Croda Recent Developments
  19. 6.4 Nanjing Well
  20. 6.4.1 Nanjing Well Company Information
  21. 6.4.2 Nanjing Well Business Overview
  22. 6.4.3 Nanjing Well Poloxamer Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nanjing Well Poloxamer Product Portfolio
  24. 6.4.5 Nanjing Well Recent Developments
  25. 6.5 Hubei Hengshuo
  26. 6.5.1 Hubei Hengshuo Company Information
  27. 6.5.2 Hubei Hengshuo Business Overview
  28. 6.5.3 Hubei Hengshuo Poloxamer Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hubei Hengshuo Poloxamer Product Portfolio
  30. 6.5.5 Hubei Hengshuo Recent Developments
  31. 6.6 Solvay
  32. 6.6.1 Solvay Company Information
  33. 6.6.2 Solvay Business Overview
  34. 6.6.3 Solvay Poloxamer Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Solvay Poloxamer Product Portfolio
  36. 6.6.5 Solvay Recent Developments
  37. 6.7 Merck KGaA
  38. 6.7.1 Merck KGaA Company Information
  39. 6.7.2 Merck KGaA Business Overview
  40. 6.7.3 Merck KGaA Poloxamer Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck KGaA Poloxamer Product Portfolio
  42. 6.7.5 Merck KGaA Recent Developments
7 North America by Country
  1. 7.1 North America Poloxamer Sales by Country
  2. 7.1.1 North America Poloxamer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Poloxamer Sales by Country (2021-2026)
  4. 7.1.3 North America Poloxamer Sales Forecast by Country (2027-2032)
  5. 7.2 North America Poloxamer Market Size by Country
  6. 7.2.1 North America Poloxamer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Poloxamer Market Size by Country (2021-2026)
  8. 7.2.3 North America Poloxamer Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Poloxamer Sales by Country
  2. 8.1.1 Europe Poloxamer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Poloxamer Sales by Country (2021-2026)
  4. 8.1.3 Europe Poloxamer Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Poloxamer Market Size by Country
  6. 8.2.1 Europe Poloxamer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Poloxamer Market Size by Country (2021-2026)
  8. 8.2.3 Europe Poloxamer Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Poloxamer Sales by Country
  2. 9.1.1 Asia-Pacific Poloxamer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Poloxamer Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Poloxamer Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Poloxamer Market Size by Country
  6. 9.2.1 Asia-Pacific Poloxamer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Poloxamer Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Poloxamer Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Poloxamer Sales by Country
  2. 10.1.1 South America Poloxamer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Poloxamer Sales by Country (2021-2026)
  4. 10.1.3 South America Poloxamer Sales Forecast by Country (2027-2032)
  5. 10.2 South America Poloxamer Market Size by Country
  6. 10.2.1 South America Poloxamer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Poloxamer Market Size by Country (2021-2026)
  8. 10.2.3 South America Poloxamer Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Poloxamer Sales by Country
  2. 11.1.1 Middle East and Africa Poloxamer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Poloxamer Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Poloxamer Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Poloxamer Market Size by Country
  6. 11.2.1 Middle East and Africa Poloxamer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Poloxamer Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Poloxamer Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Poloxamer Value Chain Analysis
  2. 12.1.1 Poloxamer Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Poloxamer Production Mode & Process
  7. 12.2 Poloxamer Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Poloxamer Distributors
  10. 12.2.3 Poloxamer Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst